Decreased Vδ2 γδ T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B

Journal of Infectious Diseases

Volumn 208, Issue 8, 2013, Pages 1294-1304

  Wu, Xiaoli ^a   Zhang, Ji Yuan ^b   Huang, Ang ^b   Li, Yuan Yuan ^b   Zhang, Song ^a   Wei, Jun ^a   Xia, Siyuan ^a   Wan, Yajuan ^a   Chen, Weiwei ^b   Zhang, Zheng ^b   Li, Yangguang ^a   Wen, Ti ^a   Chen, Yan ^b   Tanaka, Yoshimasa ^c   Cao, Youjia ^a   Wang, Puyue ^a   Zhao, Liqing ^a   Wu, Zhenzhou ^a   Wang, Fu Sheng ^b   Yin, Zhinan ^a  

^a NANKAI UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HEPATITIS B; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; LIVER INJURY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; TH17 CELL; VGAMMA2 GAMMA DELTA T LYMPHOCYTE;

ADOLESCENT; ADULT; CELL GROWTH PROCESSES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; FEMALE; FLOW CYTOMETRY; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84885070815     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit312     Document Type: Article

References (38)

1. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: Towards restoration of immune control of viral infection. Gut 2012; 61:1754-64.
2. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29.
3. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis 2007; 27:339-50.
4. Das A, Hoare M, Davies N, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008; 205:2111-24.
5. Zhang Z, Zhang JY, Wang LF, Wang FS. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol 2012; 27:223-30.
6. Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51:81-91.
7. Dong Z, Zhang J, Sun R, Wei H, Tian Z. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007; 45:1400-12.
8. Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011; 53:73-85.
9. Zhao N, Hao J, Ni Y, et al. Vgamma4 gammadelta T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol 2011; 187:5007-14.
10. Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D. Innate immune functions of human gammadelta T cells. Immunobiology 2008; 213:173-82.
11. Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology. Cancer Res 2007; 67:5-8.
12. Hayday AC. γδ Cells: A right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000; 18:975-1026.
13. Kabelitz D, HeW. The multi-functionality of human Vgamma9Vdelta2 gammadelta T-cells: Clonal plasticity or distinct subsets? Scand J Immunol 2012; 76:213-22.
14. Bonneville M, Scotet E. Human Vgamma9Vdelta2 T cells: Promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 2006; 18:539-46.
15. Poccia F, Agrati C, Martini F, Capobianchi MR, Wallace M, Malkovsky M. Antiviral reactivities of gammadelta T cells. Microbes Infect 2005; 7:518-28.
16. Poccia F, Gioia C, Martini F, et al. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells. AIDS 2009; 23:555-65.
17. Riedel DJ, Sajadi MM, Armstrong CL, et al. Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells. AIDS 2009; 23:1955-64.
18. Agrati C, D'Offizi G, Narciso P, et al. Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2001; 17:1357-63.
19. Par G, Rukavina D, Podack ER, et al. Decrease in CD3-negative- CD8dim+ and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 2002; 37:514-22.
20. Chen M, Hu P, Peng H, et al. Enhanced peripheral γδT cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression. J Clin Immunol 2012; 32:877-85.
21. Chen M, Zhang D, Zhen W, et al. Characteristics of circulating T cell receptor γδ T cells from individuals chronically infected with hepatitis B virus (HBV): An association between Vδ2 subtype and chronic HBV infection. J Infect Dis 2008; 198:1643-50.
22. European Association For The Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-85.
23. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991; 13:372-4.
24. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumorinfiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007; 27:334-48.
25. Dunn C, Peppa D, Khanna P, et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009; 137:1289-300.
26. Webster GJ, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms. Hepatology 2000; 32:1117-24.
27. Li J, Han Y, Jin K, et al. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection. Virol J 2011; 8:199.
28. Jiang X, Zhang M, Lai Q, et al. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B. PLoS ONE 2011; 6:e28871.
29. Nakamoto N, Ebinuma H, Kanai T, et al. CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis. Gastroenterology 2012; 142:366-76.
30. Sato T, Thorlacius H, Johnston B, et al. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J Immunol 2005; 174:277-83.
31. Deng G, Zhou G, Zhang R, et al. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 2008; 134:716-26.
32. Hassanshahi G, Arababadi MK, Khoramdelazad H, Yaghini N, Zarandi ER. Assessment of CXCL12 (SDF-1alpha) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran. Arch Med Res 2010; 41:338-42.
33. Wang J, Wang PP, Xiang GJ, Hu XB. Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis. Hepatobiliary Pancreat Dis Int 2010; 9:280-6.
34. Li H, Pauza CD. HIV envelope-mediated, CCR5/alpha4beta7- dependent killing of CD4-negative gammadelta T cells which are lost during progression to AIDS. Blood 2011; 118:5824-31.
35. Li B, Bassiri H, Rossman MD, et al. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: A mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis. J Immunol 1998; 161: 1558-67.
36. Agrati C, D'Offizi G, Narciso P, et al. Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons. Mol Med 2001; 7:11-9.
37. Tseng CT, Miskovsky E, Houghton M, Klimpel GR. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): Evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 2001; 33:1312-20.
38. Feng D, Kong X, Weng H, et al. Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 2012; 143:188-198.e7.